Refractory Neuroblastoma Recruiting Phase 2 Trials for Tacrolimus (DB00864)

Indication	Status	Phase
DBCOND0047201 (Refractory Neuroblastoma)	Recruiting	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT04530487	Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults	Treatment	Antithymocyte immunoglobulin (rabbit) (DB00098) Beta-D-Glucose (DB02379) Cyclosporine (DB00091) Etoposide (DB00773) Fludarabine (DB01073) Mechlorethamine (DB00888) Mycophenolate mofetil (DB00688) Tacrolimus (DB00864) Thiotepa (DB04572) Tromethamine (DB03754)